Current possibilities of assessment of quality of life in multiple sclerosis;Aktualne możliwości oceny jakości życia w stwardnieniu rozsianym

Neurologia i Neurochirurgia Polska

Volumn 40, Issue 4, 2006, Pages 336-341

  Opara, Józef ^a,b   Jaracz, Krystyna ^c   Brola, Waldemar ^d  

^a Oddzia Rehabilitacji Narzacombining Ogonekdu Ruchu   (Poland)

^b INSTITUTE OF SPORT SCIENCES   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d Szpital Rejonowy ^*  (Poland)

Author keywords

Disability; Multiple sclerosis; Quality of life

Indexed keywords

COGNITION; DATA ANALYSIS; DEPRESSION; FATIGUE; FUNCTIONAL ASSESSMENT; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSTRUMENTATION; LIFE SATISFACTION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUESTIONNAIRE; RATING SCALE; REVIEW; SHORT FORM 36; THERAPY EFFECT; COGNITIVE DEFECT; DISABILITY; DISEASE COURSE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; STANDARD;

COGNITION DISORDERS; DISABILITY EVALUATION; DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; QUALITY OF LIFE;

EID: 33749370211     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Brola W., Wegrzyn W., Czernicki J. Wpływ zmiennego pola magnetycznego na niewydolność ruchowa i jakość εzycia chorych ze stwardnieniem rozsianym. Wiad Lek 2002; 55: 136-143.
2. Fischer J.S., Priore R.L., Jacobs L.D. i wsp. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol 2000; 48: 885-892.
3. Freeman J.A., Thompson A.J., Fitzpatrick R., i wsp. European Study Group on Interferon-beta1b in Secondary Progressive MS. Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life. Neurology 2001; 57: 1870-1875.
4. Henriksson F., Fredrikson S., Masterman T. i wsp. Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neurol 2001; 8: 27-35.
5. Langdon D.W., Thompson A.J. Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 1999; 5: 94-100.
6. Vermersch P., de Seze J., Delisse B. i wsp. Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment. Mult Scler 2002; 8: 377-381.
7. Sek H. Pojecia normy, normalności i zdrowia. W: Sek H. (red.). Psychologia kliniczna. Wydawnictwo Naukowe PWN, Warszawa 2005, ss. 55-64.
8. Mitchell A.J., Banito-Leon J., Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005; 4: 556-566.
9. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36) 1: conceptual framework and item selection. Med Care 1992; 30: 473-483.
10. EuroQoL Group. EuroQoL: a new facility for the measurement of heath-related quality of life. Health Policy 1990; 16: 199-208.
11. Bergner M., Bobbit R.A, Carter W.B. i wsp. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981; 19: 787-805.
12. Testa M.A., Simonson D.C. Assessment of Quality-of-Life Outcomes. N Engl J Med 1996; 334: 835-840.
13. Fugl-Meyer A.R., Branhorn I.B., Fugl-Meyer K.S. Hapiness and domain-specific life satisfaction scale in adult Northern Sweds. Clin Rehab 1991; 5: 25-35.
14. Kaplan R.M., Bush J. W., Berry C.C. Health status: types of validity and the Index of Well-Being. Health Services Research 1976; 11: 478-507.
15. Opara J., Szeliga-Cetnarska M., Chromy M. i wsp. Skale Udarów "Repty". Wskaźnik funkcjonalny "Repty" dla oceny czynności εzycia codziennego u chorych z niedowładem połowiczym po udarze mózgowym. Cześć II. Neurol Neurochir Pol 1998; 4: 813-822.
16. Miller A., Dishon S. Health-related quality of life in multiple sclerosis: psychometric analysis of inventories Mult Scler 2005; 11: 450-458.
17. Visschedijk M.A., Uitdehaag B.M., Klein M. i wsp. Value of health-related quality of life to predict disability course in multiple sclerosis. Neurology 2004; 63: 2046-2050.
18. Vickrey B.G., Hays R.D., Harooni R. i wsp. A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4: 187-206.
19. Vickrey B.G., Hays R.D., Genovese B.J. i wsp. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J Clin Epidemiol 1997; 50: 557-569.
20. Cella D.F., Dineen K., Arnason B. i wsp. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996; 47: 129-139.
21. Gold S.M., Heesen C., Schultz H. i wsp. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler 2001; 7: 119-130.
22. Ferrans C.E., Powers M.J. Psychometric assessment of the Quality of Life Index. Res Nurs Health 1992; 15: 29-38.
23. Jaracz K., Wołowicka L., Baczyk G. Analiza walidacyjna polskiej wersji Indeksu Jakości Życia Ferrans i Powers. Post Rehab 2001; 15: 67-74.
24. Jaracz K., Kozubski W. Subiektywne i obiektywne wyznaczniki jakości εzycia osób po niedokrwiennym udarze mózgu. Gerontol Pol 2002; 10: 140-143.
25. Hobart J., Lamping D., Fitzpatrick R., Riazi A. i wsp. The Multiple Sclerosis Impact Scale (MSIS -29): a new patient-based outcome measure. Brain 2001; 124: 962-273.
26. Hobart J., Freeman J., Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000; 123: 1027-1040.
27. Fischer J.S., LaRocca N.G., Miller D.M. i wsp. Recent development of quality of life in multiple sclerosis (MS). Mult Scler 1999; 5: 251-259.
28. DiLorenzo T., Halper J., Picone M.A. i wsp. Reliability and validity of the Multiple Sclerosis Quality of Life Inventory in older individuals. Disabil Rehabil 2003; 25: 891-897.
29. Amato M.P., Ponziani G., Rossi F. i wsp. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 2001; 7: 340-344.
30. Barak Y., Lavie M., Achiron A. Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test. J Clin Neurosci 2002; 9: 629-632.
31. Benedict R.H., Fischer J.S., Archibald C.J. i wsp. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neurapsychol 2002; 16: 381-397.
32. Goldman Consensus Group. The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 2005; 11: 328-337.
33. Langdon D.W., Thompson A.J. Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 1999; 5: 94-100.
34. Rao S.M., Leo G.J., Bernardin L. i wsp. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-691.
35. Weinstein A., Schwid S.R., Schiffer R.B. i wsp. Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch Neurol 1999; 56: 319-324.
36. Ross T.P. The reliability of cluster and switch scores for the Controlled Oral Word Association Test. Arch Clin Neuropsychol 2003; 8: 153-164.
37. White A.T., Petajan J.H. Physiological measures of therapeutic response to interferon beta-1a treatment in remitting-relapsing MS. Clin Neurophysiol 2004; 115: 2364-2371.
38. Kotterba S., Orth M., Eren E. i wsp. Assessment of driving performance in patients with relapsing-remitting multiple sclerosis by a driving simulator. Eur Neurol 2003; 50: 160-164.
39. Benito-Leon J., Morales J.M., Rivera-Navarros J. Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 2002, 9: 497-502.
40. Zigmond A., Snaith R.P. The hospital anxiety and depression scale. Acta Psych Scand 1983; 67: 361-370.
41. Benedict R.H., Wahling E., Bakshi R. i wsp. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005; 321: 29-34.
42. Lobentanz I.S., Asenbaum S., Vass K. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand 2004; 110: 6-13.
43. Granger C.V., Cotter A.C.R., Hamilton B.B. i wsp. Functional assessment scales: a study of persons with multiple sclerosis. Arch Phys Med Rehabil 1990; 71: 870-875.
44. Koziol J.A., Lucero A., Sipe J.C. i wsp. Responsiveness of the Scripps neurologic rating scale during a multiple sclerosis clinical trial. Can J Neurol Sci 1999; 26: 283-289.
45. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
46. Miller D.M., Rudick R.A., Baier M. i wsp. Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler 2003; 9: 1-5.
47. Brooks R., with the EuroQol Group. EuroQol: the current state of play. Health Policy 1996; 37: 53-72.
48. Krupp L.B. Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs 2003; 17: 225-234.
49. Fisk J.D., Pontefract A., Ritvo P.G. i wsp. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9-14.
50. Janardhan V., Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 2002; 205: 51-58.
51. Merkelbach S., Sittinger H., Koening J. Is there a different impact of fatigue and physical disability on quality of life in multiple sclerosis? J Nerv Ment Dis 2002; 190: 388-393.
52. Dittner A.J., Wessely SC., Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004; 56: 157-170.
53. Krupp L.B., La Rocca N. G., Muir-Nash J. i wsp. The Fatigue Severity Scale, application to patients with multiple sclerosis and systemic lupus erythematosis. Arch Neurol 1989; 46: 1121-1123.
54. Multiple Sclerosis Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America; 1998.